BIOMAT Database Logo BIOMAT Database Logo

[Comparative hemodynamic studies with molsidomine and isosorbide dinitrate after aortocoronary bypass]. 1982

K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007548 Isosorbide Dinitrate A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action. Cardonit 40,Dilatrate,Iso-Bid,Isodinit,Isoket,Isoket Retard-120,Isomak R,Isordil,Isotrate,Nitrosorbide,Sorbitrate,Sorbonit,Dinitrate, Isosorbide,Iso Bid,IsoBid,Isoket Retard 120,Isoket Retard120
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008981 Molsidomine A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS. Morsydomine,Corpea,Corvaton,Duracoron,Fali-Cor,Korvatone,MTW-Molsidomin,Molsi 1A Pharma,Molsi-AZU,Molsi-Puren,Molsibeta,Molsicor,Molsidain,Molsidomin,Molsidomin Heumann,Molsidomin Stada,Molsidomin Von Ct,Molsidomin-Ratiopharm,Molsihexal,Molsiket,SIN-10,Sydnopharm,Fali Cor,Heumann, Molsidomin,MTW Molsidomin,Molsi AZU,Molsi Puren,Molsidomin Ratiopharm,SIN 10,SIN10,Von Ct, Molsidomin
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001026 Coronary Artery Bypass Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion. Aortocoronary Bypass,Bypass, Coronary Artery,Bypass Surgery, Coronary Artery,Coronary Artery Bypass Grafting,Coronary Artery Bypass Surgery,Aortocoronary Bypasses,Artery Bypass, Coronary,Artery Bypasses, Coronary,Bypass, Aortocoronary,Bypasses, Aortocoronary,Bypasses, Coronary Artery,Coronary Artery Bypasses

Related Publications

K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
Hemodynamic response to molsidomine in patients with ischemic cardiomyopathy tolerant to isosorbide dinitrate.
December 1991, Journal of cardiovascular pharmacology,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
Hemodynamic effects of molsidomine, isosorbide dinitrate, and nifedipine at rest and during exercise.
March 1985, American heart journal,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
[Molsidomine and isosorbide dinitrate:/their comparative effectiveness in patients with exertion-induced stenocardia].
July 1988, Kardiologiia,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
Comparison of the hemodynamic responses to molsidomine and isosorbide dinitrate in congestive heart failure.
September 1994, American heart journal,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
January 1990, Clinical therapeutics,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
Comparative study of the haemodynamic effects of oral molsidomine and isosorbide dinitrate in man.
January 1982, European journal of clinical pharmacology,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate.
May 1992, European heart journal,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
Clinical comparison of antiischemic efficacy of isosorbide dinitrate and molsidomine.
January 1998, Journal of cardiovascular pharmacology,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
[Comparative antianginal, hemodynamic and pharmacokinetic effects of isosorbide-2-mononitrate and isosorbide dinitrate in the rat].
January 1983, Arzneimittel-Forschung,
K W Fritz, and P Eglins, and B Höge, and F W Hehrlein, and E Lüllwitz, and E Kirchner
SYSTEMIC AND CORONARY HEMODYNAMIC EFFECTS OF ISOSORBIDE DINITRATE.
November 1963, The American journal of the medical sciences,
Copied contents to your clipboard!